{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:50:15Z","timestamp":1792601415368,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100001299","name":"Prevent Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001299","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.transproceed.2023.06.016","type":"journal-article","created":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T16:32:02Z","timestamp":1697128322000},"page":"2079-2084","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Oral Nicotinamide for Actinic Keratosis Prevention in Kidney Transplant Recipients: A Pilot Double-Blind, Randomized, Placebo-Controlled Trial"],"prefix":"10.1016","volume":"55","author":[{"given":"Helen","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth A.","family":"George-Washburn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly B.","family":"Hashemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunyoung","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin A.","family":"Weinstock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Bostom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Robinson-Bostom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1496-0833","authenticated-orcid":false,"given":"Reginald","family":"Gohh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2023.06.016_bib0001","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1001\/jamadermatol.2015.1187","article-title":"Incidence estimate of nonmelanoma skin cancer (keratinocyte carcinomas) in the U.S. population, 2012","volume":"151","author":"Rogers","year":"2015","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.transproceed.2023.06.016_bib0002","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/00007890-199003000-00006","article-title":"Incidence of skin cancer after renal transplantation in The Netherlands","volume":"49","author":"Hartevelt","year":"1990","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2023.06.016_bib0003","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/S0041-1345(96)00152-2","article-title":"Skin tumours posttransplantation: a retrospective analysis of 28 years' experience at a single centre","volume":"29","author":"Webb","year":"1997","journal-title":"Transplant Proc"},{"issue":"2 Pt 1","key":"10.1016\/j.transproceed.2023.06.016_bib0004","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0190-9622(99)70185-4","article-title":"Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens","volume":"40","author":"Jensen","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.transproceed.2023.06.016_bib0005","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1056\/NEJMra022137","article-title":"Skin cancers after organ transplantation","volume":"348","author":"Euvrard","year":"2003","journal-title":"New Engl J Med"},{"key":"10.1016\/j.transproceed.2023.06.016_bib0006","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.amepre.2014.08.036","article-title":"Prevalence and costs of skin cancer treatment in the U.S., 2002-2006 and 2007-2011","volume":"48","author":"Guy","year":"2015","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.transproceed.2023.06.016_bib0007","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002807","article-title":"HPV 5 and 8 E6 abrogate ATR activity resulting in increased persistence of UVB induced DNA damage","volume":"8","author":"Wallace","year":"2012","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.transproceed.2023.06.016_bib0008","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.arr.2015.01.001","article-title":"Oxidation events and skin aging","volume":"21","author":"Kammeyer","year":"2015","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.transproceed.2023.06.016_bib0009","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.jaci.2009.01.043","article-title":"UV-B radiation induces the expression of antimicrobial peptides in human keratinocytes in vitro and in vivo","volume":"123","author":"Gl\u00e4ser","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.transproceed.2023.06.016_bib0010","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1093\/jnci\/59.4.1227","article-title":"In vivo immune responses of mice during carcinogenesis by ultraviolet irradiation","volume":"59","author":"Kripke","year":"1977","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.transproceed.2023.06.016_bib0011","doi-asserted-by":"crossref","first-page":"S100","DOI":"10.1016\/j.jaad.2016.09.038","article-title":"Ultraviolet radiation and the skin: photobiology and sunscreen photoprotection","volume":"76","author":"Young","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.transproceed.2023.06.016_bib0012","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1097\/00007890-199603150-00008","article-title":"The risk of skin cancer in renal transplant recipients in Queensland, Australia. A follow-up study","volume":"61","author":"Bouwes Bavinck","year":"1996","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2023.06.016_bib0013","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/exd.13819","article-title":"Nicotinamide for photoprotection and skin cancer chemoprevention: a review of efficacy and safety","volume":"28","author":"Snaidr","year":"2019","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.transproceed.2023.06.016_bib0014","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1038\/jid.2011.459","article-title":"Oral nicotinamide reduces actinic keratoses in phase II double-blinded randomized controlled trials","volume":"132","author":"Surjana","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.transproceed.2023.06.016_bib0015","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1056\/NEJMoa1506197","article-title":"A phase 3 randomized trial of nicotinamide for skin-cancer chemoprevention","volume":"373","author":"Chen","year":"2015","journal-title":"New Engl J Med"},{"key":"10.1016\/j.transproceed.2023.06.016_bib0016","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1111\/bjd.14662","article-title":"A phase II randomized controlled trial of nicotinamide for skin cancer chemoprevention in renal transplant recipients","volume":"175","author":"Chen","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.transproceed.2023.06.016_bib0017","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1056\/NEJMc1514791","article-title":"Nicotinamide for skin-cancer chemoprevention","volume":"374","author":"Drago","year":"2016","journal-title":"New Engl J Med"},{"key":"10.1016\/j.transproceed.2023.06.016_bib0018","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1684\/ejd.2017.3025","article-title":"Prevention of non-melanoma skin cancers with nicotinamide in transplant recipients: a case-control study","volume":"27","author":"Drago","year":"2017","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.transproceed.2023.06.016_bib0019","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0197-2456(88)90048-7","article-title":"Properties of the urn randomization in clinical trials","volume":"9","author":"Wei","year":"1988","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.transproceed.2023.06.016_bib0020","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1053\/j.ajkd.2010.06.029","article-title":"Once-daily extended-release niacin lowers serum phosphorus concentrations in patients with metabolic syndrome dyslipidemia","volume":"57","author":"Hu","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.transproceed.2023.06.016_bib0021","first-page":"963","article-title":"Sustained hypophosphatemic effect of once-daily niacin\/laropiprant in dyslipidemic CKD stage 3 patients","volume":"57","author":"Ix","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.transproceed.2023.06.016_bib0022","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1074\/jbc.273.1.1","article-title":"The p53 network","volume":"273","author":"Agarwal","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.transproceed.2023.06.016_bib0023","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1177\/1947601913476948","article-title":"Deacetylation by SIRT1 reprograms inflammation and cancer","volume":"4","author":"Liu","year":"2013","journal-title":"Genes Cancer"},{"key":"10.1016\/j.transproceed.2023.06.016_bib0024","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0092-8674(01)00527-X","article-title":"hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase","volume":"107","author":"Vaziri","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.transproceed.2023.06.016_bib0025","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1001\/jamadermatol.2021.3180","article-title":"Consensus-based recommendations on the prevention of squamous cell carcinoma in solid organ transplant recipients: a Delphi Consensus Statement","volume":"157","author":"Massey","year":"2021","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.transproceed.2023.06.016_bib0026","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/bjd.15203","article-title":"Reply to \u2018A phase II randomized controlled trial of nicotinamide for skin cancer chemoprevention in renal transplant recipients","volume":"176","author":"Y\u00e9lamos","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.transproceed.2023.06.016_bib0027","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1056\/NEJMc1514791","article-title":"Nicotinamide for skin-cancer chemoprevention","volume":"374","author":"Zhao","year":"2016","journal-title":"New Engl J Med"},{"key":"10.1016\/j.transproceed.2023.06.016_bib0028","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/bjd.15204","article-title":"Authors\u2019 response to a reply to \u2018A phase II randomized controlled trial of nicotinamide for skin cancer chemoprevention in renal transplant recipients","volume":"176","author":"Damian","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.transproceed.2023.06.016_bib0029","first-page":"58","article-title":"Oral nicotinamide reduces serum phosphorus, increases HDL, and induces thrombocytopenia in hemodialysis patients: a double-blind randomized clinical trial","volume":"31","author":"Shahbazian","year":"2011","journal-title":"Nefrologia"},{"key":"10.1016\/j.transproceed.2023.06.016_bib0030","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1016\/j.jacc.2018.04.020","article-title":"Supplemental vitamins and minerals for CVD prevention and treatment","volume":"71","author":"Jenkins","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.transproceed.2023.06.016_bib0031","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1056\/NEJMoa2203086","article-title":"Nicotinamide for skin-cancer chemoprevention in transplant recipients","volume":"388","author":"Allen","year":"2023","journal-title":"New Engl J Med"},{"key":"10.1016\/j.transproceed.2023.06.016_bib0032","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1111\/bjd.15950","article-title":"Research gaps in the management and prevention of cutaneous squamous cell carcinoma in organ transplant recipients","volume":"177","author":"Blomberg","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.transproceed.2023.06.016_bib0033","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/ajd.12749","article-title":"Nicotinamide and skin cancer chemoprevention: the jury is still out","volume":"59","author":"Gilmore","year":"2018","journal-title":"Australas J Dermatol"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134523005511?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134523005511?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:45:51Z","timestamp":1758577551000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134523005511"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":33,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S0041134523005511"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2023.06.016","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral Nicotinamide for Actinic Keratosis Prevention in Kidney Transplant Recipients: A Pilot Double-Blind, Randomized, Placebo-Controlled Trial","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2023.06.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}